Chemical Compound

budesonide

CAS Registry Number 51333-22-3

Back to search Request a Quote

Primary Record

budesonide

In stock: 8,371 g
Purity: 99.0 %
CAS: 51333-22-3

Compound Identifiers & Properties

CAS: 51333-22-3
PubChem CID: 5281004
SMILES: CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@@]5([C@H]4[C@H](C[C@@]3([C@@]2(O1)C(=O)CO)C)O)C
Canonical SMILES: CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1

Names & Synonyms

budesonide
Pulmicort
Rhinocort
Entocort
Preferid
Budeson
Rhinocort Aqua
Spirocort
Uceris
Entocort EC
Cortivent
Micronyl
Respules
Bidien
Budenofalk
Budesonido
Budesonidum
Pulmicort Respules
Rhinocort alpha
Horacort
Pulmaxan
Pulmicort Flexhaler
Budecort Inhaler
Dexbudesonide
Budesomide
Budesonida
Inflammide
Cortiment
Miflonide
Budiair
Tarpeyo
51333-22-3
Eltair
Fvolir
Rhinocort Allergy
barazone
Budesonide MMX
Turbuhaler
Budecort
Butacort
Nasocort
Nebuampul
Aircort
GionaEasyhaler
Jorveza
Ultesa
Pulmicort turbuhaler
Noex
Giona Easyhaler
Entocort cr
Inflammide;
Pulmicort;
Rhinocort;
Duoresp spiromax
Demotest;
Entocort;
Lisoflam;
Prederid;
Preferid;
Pulmaxan turbohaler
Pulmaxan;
Budesonide RS
EOHILIA
Pulmicort (TN)
Rhinocort (TN)
Budamax;
Budeson;
Nohalon;
Pulmicort Topinasal
Budesonide CRS
Budeflam aquanase
Budelin novolizer
Pulmicort Nebuamp
Budesonide Easyhaler
Olfex;
Pulmicort l.s.
(R)-Budesonide
Budesonide - IP
ORTIKOS
Unit dosebudesonide
Budesonidum [INN-Latin]
Entocort EC (TN)
Dexbudesonide [INN]
Budesonido [INN-Spanish]
Entocort (TN)
Budesonide (Standard)
Prestwick_840
Rhinocort aqua 64
Rhinocort Turbuhaler
Uceris (TN)
Budesonide Inhalation
(22R)-Budesonide
Noex (TN)
Q3OKS62Q6X
RefChem:5621
Budesonide, >=99%
BUDESONIDE [MI]
UNII-Q3OKS62Q6X
DTXSID8020202
BUDESONIDE [INN]
BUDESONIDE [JAN]
Budesonide, (R)-Isomer
Budesonide, (S)-Isomer
C25H34O6
MAP-0010
Opera_ID_1696
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
BUDESONIDE [USAN]
CCRIS 5230
CHEBI:3207
VOVIALXJUBGFJZ-KWVAZRHASA-N
Budesonide [USAN:INN:BAN:JAN]
BUDESONIDE [VANDF]
D0Y7IU
Epitope ID:161750
MAP0010
MLS000028507
R01AD05
SCHEMBL4096
BUDESONIDE [USP-RS]
BUDESONIDE [WHO-DD]
CHEMBL1370
UNII-2HI1006KPH
Lopac0_000174
MFCD00083259
BSPBio_000475
MLS001077323
MLS002207112
orb134514
Budesonide (JAN/USAN/INN)
Budesonide (anti-inflammatory)
DTXCID50820058
EINECS 257-139-7
S-1320
SPBio_002396
UCERIS COMPONENT BUDESONIDE
BPBio1_000523
BREZTRI COMPONENT BUDESONIDE
Budesonide (JP18/USP/INN)
Budesonide - Bio-X trade mark
GTPL7434
Budesonide Inhalation Suspension
AIRSUPRA COMPONENT BUDESONIDE
BUDESONIDE [ORANGE BOOK]
NSC-757788
ERK5-2K22
HSDB 8279
A07EA06
BUDESONIDE [EP MONOGRAPH]
D07AC09
MSK2236
R03BA02
17-PA
BUDESONIDE [USP MONOGRAPH]
HMS1569H17
HMS2096H17
HMS2232D17
HMS3259H07
HMS3260D09
HMS3413B08
HMS3413P17
HMS3677B08
HMS3677P17
HMS3713H17
S 1320
BUDESONIDE (ENTERIC COATED)
Budesonide [USAN:BAN:INN:JAN]
ACT03247
BCP05589
EINECS 257-161-7
Eohilia (budesonide oral suspension)
Tox21_110653
Tox21_201827
Tox21_302815
Tox21_500174
BDBM50354850
EBC-27074
HY-13580R
MSK2236-100A
SYMBICORT COMPONENT BUDESONIDE
BUDESONIDE (11beta,16alpha(R))
Budesonide (Mixture of Diastereomers)
Budesonide for system suitability CRS
SMR000058337
AKOS015969655
MSK2236-1000A
AC-4697
ACN-043365
C25-H34-O6
CCG-204269
CID5281004
CS-2063
CS-O-00981
DB01222
FB19346
KS-1162
LP00174
LS-7235
NC00626
NSC 757788
RL03890
SDCCGSBI-0050162.P002
CID:5281004
NCGC00016862-01
NCGC00021318-05
NCGC00021318-06
NCGC00021318-08
NCGC00021318-18
NCGC00089747-04
NCGC00256415-01
NCGC00259376-01
NCGC00260859-01
51372-29-3
BB164267
Budesonide 100 microg/mL in Acetonitrile
CPD000058337
FB173257
H040
HY-13580
J11.656D
SC-71383
SID:53789711
B 7777
CAS-51333-22-3
B3909
CS-0695032
EU-0100174
NS00000099
ST24046248
4-Chlorophenyl-N-methylhydrazonopropanedinitrile
5301-EP2270008A1
5301-EP2280006A1
5301-EP2281563A1
5301-EP2281813A1
5301-EP2281815A1
5301-EP2281819A1
5301-EP2292617A1
5301-EP2292619A1
5301-EP2295402A2
5301-EP2295408A1
5301-EP2301933A1
5301-EP2305640A2
5301-EP2305659A1
5301-EP2308562A2
5301-EP2311818A1
5301-EP2311827A1
5301-EP2314590A1
5301-EP2316459A1
5301-EP2371811A2
Budesonide Solution in Acetonitrile, 100ug/mL
D00246
T70986
Budesonide Solution in Acetonitrile, 1000ug/mL
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
333B223
D019819
EN300-19737584
Q422212
SR-01000000101
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
A1031038
Budesonide for System Suitability CRS (Y0001148)
SR-01000000101-2
SR-01000000101-6
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
BRD-A34299591-001-03-4
BRD-A34299591-001-22-4
BRD-A34299591-001-25-7
BRD-A34299591-001-26-5
Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
16a(R),17-(Butylidenebis(oxy))-11b,21-dihydroxypre
Budesonide Working Standard (Secondary Reference Standard)
Budesonide, European Pharmacopoeia (EP) Reference Standard
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
Budesonide, United States Pharmacopeia (USP) Reference Standard
(+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16A(R),17-(BUTYLIDENEBIS(OXY))-11B,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material
Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-
Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
(11?,16?)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11|A,16|A)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11b,16a)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11S,16R,17S)-16,17-Butylidenebisoxy-11,21-dihydroxypregna-1,4-diene-3,20-dione
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-Dihydroxy-16alpha,17-(butylidenebisoxy)pregna-1,4-diene-3,20-dione
11beta,21-Dihydroxy-16alpha,17-(butylidenedioxy)pregna-1,4-diene-3,20-dione
11beta,21-Dihydroxy-16alpha,17alpha-(butylidenedioxy)pregna-1,4-diene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha(R),17-[butylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha,17-[Butylidenebis(oxy)]-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha,17alpha-Butylidenebisoxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha,17alpha-Butylidenebisoxy-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
16alpha-,17alpha-butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
(11-beta,16-alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosa-14,17-dien-16-one
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-Hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H,8H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
(R,S)-11-beta,16-alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
257-139-7
5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
51333-22-3 [11(gr b), 16(gr a)] 51372-29-3 [(11(gr b), 16(gr a)[//R//])] 51372-28-2 [(11(gr b), 16(gr a)[//S//])]
BUD
Budesonide; 16a,17-[(1RS)-butylidenebis(oxy)]-11ss,21-dihydroxypregna-1,4-diene-3,20-dione
Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, [11.beta.,16.alpha.(R)]-
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-,and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
UDB